A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

查看全文 作　　者：Chao [1]Jiang;Miao [1]Mei;Bin [2]Li;Xiurui [3]Zhu;Wenhong [1]Zu;Yujie [1]Tian;Qiannan [1]Wang;Yong [3]GUO;Yizhou [2]Dong;Xu [1]Tan

机构地区：[1]School of Pharmaceutical Sciences, Center for Infectious Disease Research, School of Medicine, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China;[2]Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA;[3]Department of Biomedical Engineering, School of Medicine, Tsinghua University, Beijing 100084, China

出　　处：《Cell Research》索引2017年第27卷第3期,共4页

相关文献

参考文献（15）
引证文献（17）
耦合文献（0）

参考文献(15)

引证文献(17)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

A non-viral CRISPR/Cas9 delivery system for therapeutically targeting HBV DNA and pcsk9 in vivo

参考文献(15)

引证文献(17)

用户提示